Witnessing the stock’s movement on the chart, on Wednesday, Cerus Corp (NASDAQ: CERS) set off with pace as it heaved 5.00% to $1.68, before settling in for the price of $1.6 at the close. Taking a more long-term approach, CERS posted a 52-week range of $1.12-$2.23.
It was noted that the giant of the Healthcare sector posted annual sales growth of 25.97% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 25.97%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -6.82%. This publicly-traded company’s shares outstanding now amounts to $191.59 million, simultaneously with a float of $179.15 million. The organization now has a market capitalization sitting at $322.06 million. At the time of writing, stock’s 50-day Moving Average stood at $1.3460, while the 200-day Moving Average is $1.4582.
Cerus Corp (CERS) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Medical Devices industry. Cerus Corp’s current insider ownership accounts for 6.55%, in contrast to 76.59% institutional ownership. According to the most recent insider trade that took place on Aug 25 ’25, this organization’s Director bought 25,000 shares at the rate of 1.25, making the entire transaction reach 31,250 in total value, affecting insider ownership by 86,725. Preceding that transaction, on Mar 14 ’25, Company’s Chief Legal Officer sold 30,075 for 1.45, making the whole transaction’s value amount to 43,609. This particular insider is now the holder of 783,294 in total.
Cerus Corp (CERS) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.01 per share during the current fiscal year.
Cerus Corp’s EPS decrease for this current 12-month fiscal period is -6.82% and is forecasted to reach -0.07 in the upcoming year.
Cerus Corp (NASDAQ: CERS) Trading Performance Indicators
Let’s observe the current performance indicators for Cerus Corp (CERS). It’s Quick Ratio in the last reported quarter now stands at 1.35. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.67. Similarly, its price to free cash flow for trailing twelve months is now 94.17.
In the same vein, CERS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.10, a figure that is expected to reach -0.03 in the next quarter, and analysts are predicting that it will be -0.07 at the market close of one year from today.
Technical Analysis of Cerus Corp (CERS)
Going through the that latest performance of [Cerus Corp, CERS]. Its last 5-days volume of 1.34 million was inferior to the volume of 1.34 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 79.48% While, its Average True Range was 70.20.
Raw Stochastic average of Cerus Corp (CERS) in the period of the previous 100 days is set at 96.36%, which indicates a major rise in contrast to 94.94% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.1086 that was higher than 0.0790 volatility it exhibited in the past 100-days period.
